MARC record from Internet Archive

LEADER: 03612cam a22004094a 4500
001 2006018969
003 DLC
005 20140702132211.0
008 060609s2007 paua b 001 0 eng
010 $a 2006018969
015 $aGBA660857$2bnb
016 7 $a101278827$2DNLM
016 7 $a013507810$2Uk
020 $a0781778816
020 $a9780781778817
035 $a(OCoLC)ocm70119702
040 $aDNLM/DLC$cDLC$dNLM$dBAKER$dC#P$dVAM$dJVD$dBTCTA$dYDXCP$dUKM$dDLC
042 $apcc
050 00 $aRC382$b.P257 2007
060 00 $a2006 M-506
060 10 $aWL 359$bP2473 2007
082 00 $a616.8/33$222
245 00 $aParkinson's disease and movement disorders /$ceditors, Joseph Jankovic, Eduardo Tolosa.
246 14 $aParkinson's disease & movement disorders
250 $a5th ed.
260 $aPhiladelphia :$bLippincott Williams & Wilkins,$cc2007.
300 $axiv, 720 p. :$bill. (some col.) ;$c29 cm. +$e1 CD-ROM (4 3/4 in.)
504 $aIncludes bibliographical references and index.
505 00 $tFunctional organization of the basal ganglia --$tNeurophysiology of motor control and movement disorders --$tNeurobehavioral disorders associated with basal ganglia lesions --$tProtein mishandling: role of the ubiquitin proteasome system in the pathogenesis of Parkinson's disease --$tEpidemiology of movement disorders --$tNonmotor symptoms in Parkinson's disease --$tEtiology and pathogenesis of Parkinson's isease --$tGenetics of Parkinson's disease --$tDisease-modifying strategies in Parkinson's Disease --$tPharmacological management of Parkinson's disease --$tExperimental therapeutics of Parkinson's disease and the development of new symptomatic medicines for Parkinson's disease --$tDementia associated with Parkinson's disease: features and management --$tProgressive supranuclear palsy --$tMultiple system atrophy --$tCorticobasal degeneration --$tInherited and sporadic tauopathies --$tSecondary Parkinson's syndrome --$tHuntington's disease --$tChorea, ballism, and athetosis --$tNeurodegeneration with brain iron accumulation --$tNeurologic aspects of Wilson's disease: clinical manifestations and treatment considerations --$tNeuropathology of parkinsonian disorders --$tMitochondria in movement disorders --$tTremors: differential diagnosis, pathophysiology, and therapy --$tDystonic disorders --$tTreatment of dystonia --$tTics and tourette's syndrome --$tMyoclonus and startle syndromes --$tTreatment of myoclonus --$tDrug-induced movement disorders --$tRestless legs syndrome --$tHereditary ataxias --$tDisorders of gait --$tParoxysmal dyskinesias: an overview --$tSterotypy and catatonia --$tMovement disorders in children --$tRigidity and spasticity --$tMuscle cramps, stiffness, and myalgia --$tAssessment of behavior in Parkinsonian disorders --$tPsychogenic movement disorders --$tNeuroacanthocytosis --$tPrion disease --$tFunctional neuroimaging in movement disorders --$tBotulinum toxin in movement disorders --$tSurgery for Parkinson's disease and hyperkinetic movement disorders --$tBeing realistc about human embryonic stem cell-based therapy for Parkinson's disease --$tDeep-brain stimulation for movement disorders --$tClinical rating scales in movement disorders.
650 0 $aParkinson's disease.
650 0 $aMovement disorders.
650 12 $aParkinson Disease.
650 22 $aMovement Disorders.
700 1 $aJankovic, Joseph.
700 1 $aTolosa, Eduardo.
856 41 $3Table of contents only$uhttp://www.loc.gov/catdir/toc/ecip0615/2006018969.html
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/enhancements/fy0712/2006018969-d.html